Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2019 Jul 1;129(7):2980. doi: 10.1172/JCI130874. Epub 2019 Jul 1. No abstract available.

2.

Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.

Porter CK, Riddle MS, Gutierrez RL, Princen F, Strauss R, Telesco SE, Torres J, Choung RS, Laird RM, Leon F, Colombel JF, Murray JA; PREDICTS study team.

Contemp Clin Trials Commun. 2019 Mar 26;14:100345. doi: 10.1016/j.conctc.2019.100345. eCollection 2019 Jun.

3.

Clinical endpoints for efficacy studies.

Porter CK, Gutierrez RL, Kotloff KL.

Vaccine. 2019 Aug 7;37(34):4814-4822. doi: 10.1016/j.vaccine.2019.03.051. Epub 2019 Apr 10.

4.

Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs.

Riddle MS, Ericsson CD, Gutierrez RL, Porter CK.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay099. No abstract available.

PMID:
30312427
5.

Enterotoxigenic E. coli virulence gene regulation in human infections.

Crofts AA, Giovanetti SM, Rubin EJ, Poly FM, Gutiérrez RL, Talaat KR, Porter CK, Riddle MS, DeNearing B, Brubaker J, Maciel M Jr, Alcala AN, Chakraborty S, Prouty MG, Savarino SJ, Davies BW, Trent MS.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8968-E8976. doi: 10.1073/pnas.1808982115. Epub 2018 Aug 20.

6.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2018 Aug 1;128(8):3298-3311. doi: 10.1172/JCI97659. Epub 2018 Jun 25. Erratum in: J Clin Invest. 2019 Jul 1;129(7):2980.

7.

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

Porter CK, Lynen A, Riddle MS, Talaat K, Sack D, Gutiérrez RL, McKenzie R, DeNearing B, Feijoo B, Kaminski RW, Taylor DN, Kirkpatrick BD, Bourgeois AL.

PLoS One. 2018 Mar 28;13(3):e0194325. doi: 10.1371/journal.pone.0194325. eCollection 2018.

8.

Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Crofts AA, Poly FM, Ewing CP, Kuroiwa JM, Rimmer JE, Harro C, Sack D, Talaat KR, Porter CK, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Maue AC, Jaep K, Alcala A, Tribble DR, Riddle MS, Ramakrishnan A, McCoy AJ, Davies BW, Guerry P, Trent MS.

Nat Microbiol. 2018 Apr;3(4):494-502. doi: 10.1038/s41564-018-0133-7. Epub 2018 Mar 27.

9.

Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.

Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS.

Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014.

PMID:
29145631
10.

Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.

Riddle MS, Connor P, Fraser J, Porter CK, Swierczewski B, Hutley EJ, Danboise B, Simons MP, Hulseberg C, Lalani T, Gutierrez RL, Tribble DR; TrEAT TD Study Team.

Clin Infect Dis. 2017 Nov 29;65(12):2008-2017. doi: 10.1093/cid/cix693.

11.

Review: chronic and persistent diarrhea with a focus in the returning traveler.

Duplessis CA, Gutierrez RL, Porter CK.

Trop Dis Travel Med Vaccines. 2017 May 4;3:9. doi: 10.1186/s40794-017-0052-2. eCollection 2017. Review.

12.

Giardia lamblia infection increases risk of chronic gastrointestinal disorders.

Dormond M, Gutierrez RL, Porter CK.

Trop Dis Travel Med Vaccines. 2016 Aug 30;2:17. doi: 10.1186/s40794-016-0030-0. eCollection 2016.

13.

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.

Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, Weerts HE, Duplessis C, Castellano A, Alaimo C, Paolino K, Gormley R, Gambillara Fonck V.

Clin Vaccine Immunol. 2016 Dec 5;23(12):908-917. Print 2016 Dec.

14.

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Porter CK, Riddle MS, Alcala AN, Sack DA, Harro C, Chakraborty S, Gutierrez RL, Savarino SJ, Darsley M, McKenzie R, DeNearing B, Steinsland H, Tribble DR, Bourgeois AL.

PLoS One. 2016 Mar 3;11(3):e0149358. doi: 10.1371/journal.pone.0149358. eCollection 2016.

15.

Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010).

Gutiérrez RL, Riddle MS, Porter CK.

Gastroenterology. 2015 Nov;149(6):1408-14. doi: 10.1053/j.gastro.2015.07.059. Epub 2015 Aug 7.

PMID:
26255560
16.

Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study.

McCarroll MG, Riddle MS, Gutierrez RL, Porter CK.

Dig Dis Sci. 2015 Nov;60(11):3379-85. doi: 10.1007/s10620-015-3768-8. Epub 2015 Jun 27.

PMID:
26115751
17.

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, Kwilas SA, Van Deusen N, Mbaya OT, Zhou Y, Stanley DA, Jing W, Smith KS, Shi M, Ledgerwood JE, Graham BS, Sullivan NJ, Jagodzinski LL, Peel SA, Alimonti JB, Hooper JW, Silvera PM, Martin BK, Monath TP, Ramsey WJ, Link CJ, Lane HC, Michael NL, Davey RT Jr, Thomas SJ; rVSVΔG-ZEBOV-GP Study Group.

N Engl J Med. 2017 Jan 26;376(4):330-341. doi: 10.1056/NEJMoa1414216. Epub 2015 Apr 1.

18.

Effects of pre-deployment loperamide provision on use and travelers' diarrhea outcomes among U.S. military personnel deployed to Turkey.

Letizia A, Riddle MS, Tribble D, Mostafa M, Monteville M, Armstrong A, Gutierrez RL.

Travel Med Infect Dis. 2014 Jul-Aug;12(4):360-3. doi: 10.1016/j.tmaid.2013.12.007. Epub 2014 Jan 21.

PMID:
24485100
19.

Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998-2010).

Gutiérrez RL, Riddle MS, Porter CK.

BMC Infect Dis. 2013 Dec 28;13:609. doi: 10.1186/1471-2334-13-609.

20.

Update on military diarrhoea: current status and future plans.

Connor P, Gutierrez RL.

J R Army Med Corps. 2013 Sep;159(3):136-40. doi: 10.1136/jramc-2013-000091. Epub 2013 May 29. No abstract available.

PMID:
24109132
21.

Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Deising A, Gutierrez RL, Porter CK, Riddle MS.

Gastroenterol Hepatol (N Y). 2013 Mar;9(3):145-57.

22.

Fever, dyspnea, and hepatitis in an Iraq veteran.

Gutiérrez RL, Hartzell JD.

Cleve Clin J Med. 2012 Sep;79(9):623-30. doi: 10.3949/ccjm.79a.11136. No abstract available.

PMID:
22949343
23.

Dynamic breast MRI: does lower temporal resolution negatively affect clinical kinetic analysis?

Gutierrez RL, Strigel RM, Partridge SC, DeMartini WB, Eby PR, Stone KM, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2012 Sep;199(3):703-8. doi: 10.2214/AJR.11.7836.

PMID:
22915415
24.

The chronic gastrointestinal consequences associated with campylobacter.

Riddle MS, Gutierrez RL, Verdu EF, Porter CK.

Curr Gastroenterol Rep. 2012 Oct;14(5):395-405. doi: 10.1007/s11894-012-0278-0. Review.

PMID:
22864805
25.

Management of service members presenting with persistent and chronic diarrhea, during or upon returning from deployment.

Gutiérrez RL, Goldberg M, Young P, Tribble DR, Connor P, Porter CK, Riddle MS.

Mil Med. 2012 Jun;177(6):627-34.

PMID:
22730836
26.

Prevention of tick-borne illness.

Gutiérrez RL, Decker CF.

Dis Mon. 2012 Jun;58(6):377-87. doi: 10.1016/j.disamonth.2012.03.009. No abstract available.

PMID:
22608125
27.

In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

Radiology. 2012 May;263(2):374-82. doi: 10.1148/radiol.12111368.

28.

Background parenchymal enhancement on breast MRI: impact on diagnostic performance.

DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD.

AJR Am J Roentgenol. 2012 Apr;198(4):W373-80. doi: 10.2214/AJR.10.6272.

PMID:
22451576
29.

Improved B1 homogeneity of 3 Tesla breast MRI using dual-source parallel radiofrequency excitation.

Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Parsian S, Lehman CD.

J Magn Reson Imaging. 2012 May;35(5):1222-6. doi: 10.1002/jmri.23571. Epub 2012 Jan 26.

30.

Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.

Rahbar H, Partridge SC, Eby PR, Demartini WB, Gutierrez RL, Peacock S, Lehman CD.

Eur Radiol. 2011 Sep;21(9):2011-9. doi: 10.1007/s00330-011-2140-4. Epub 2011 May 12.

PMID:
21562806
31.

The utility of breast MRI as a problem-solving tool.

Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD.

Breast J. 2011 May-Jun;17(3):273-80. doi: 10.1111/j.1524-4741.2011.01075.x. Epub 2011 Apr 8.

PMID:
21477168
32.

Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.

Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD.

Eur Radiol. 2011 Aug;21(8):1609-17. doi: 10.1007/s00330-011-2094-6. Epub 2011 Feb 27.

PMID:
21359910
33.

High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.

Gutierrez RL, DeMartini WB, Silbergeld JJ, Eby PR, Peacock S, Javid SH, Lehman CD.

AJR Am J Roentgenol. 2011 Jan;196(1):W93-9. doi: 10.2214/AJR.10.4804.

PMID:
21178040
34.

Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications.

Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2010 Dec;195(6):1472-7. doi: 10.2214/AJR.10.4396.

PMID:
21098212
35.

Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.

Strigel RM, Eby PR, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2010 Sep;195(3):792-8. doi: 10.2214/AJR.09.4081.

PMID:
20729462
36.

Blood-borne infections and the athlete.

Gutierrez RL, Decker CF.

Dis Mon. 2010 Jul;56(7):436-42. doi: 10.1016/j.disamonth.2010.05.004. Review. No abstract available.

PMID:
20621217
37.

Probably benign lesions detected on breast MR imaging.

Eby PR, DeMartini WB, Gutierrez RL, Lehman CD.

Magn Reson Imaging Clin N Am. 2010 May;18(2):309-21, x. doi: 10.1016/j.mric.2010.02.006. Review.

PMID:
20494314
38.

Rhabdomyolysis and pandemic (H1N1) 2009 pneumonia in adult.

Gutierrez RL, Ellis MW, Decker CF.

Emerg Infect Dis. 2010 Mar;16(3):565. doi: 10.3201/eid1603.091818. No abstract available.

39.

Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.

Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, Lehman CD.

Radiology. 2010 Jun;255(3):723-30. doi: 10.1148/radiol.09091406. Epub 2010 Feb 19.

PMID:
20173103
40.

Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips.

Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, Anderson BO, Byrd DR, Mann GN, Lehman CD.

Acad Radiol. 2010 Mar;17(3):340-7. doi: 10.1016/j.acra.2009.10.017. Epub 2009 Dec 30.

PMID:
20042350
41.

BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.

Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Oct;193(4):994-1000. doi: 10.2214/AJR.08.1983.

PMID:
19770321
42.

Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions.

Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD.

Acad Radiol. 2009 Oct;16(10):1281-5. doi: 10.1016/j.acra.2009.04.012.

PMID:
19733804
43.

Characteristics of probably benign breast MRI lesions.

Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Sep;193(3):861-7. doi: 10.2214/AJR.08.2096.

PMID:
19696303
44.

Heavy metals in water of the San Pedro River in Chihuahua, Mexico and its potential health risk.

Gutiérrez RL, Rubio-Arias H, Quintana R, Ortega JA, Gutierrez M.

Int J Environ Res Public Health. 2008 Jun;5(2):91-8.

45.

Lamotrigine augmentation strategy for patients with treatment-resistant depression.

Gutierrez RL, McKercher RM, Galea J, Jamison KL.

CNS Spectr. 2005 Oct;10(10):800-5.

PMID:
16400242

Supplemental Content

Loading ...
Support Center